Skip to the page

Data / Form D filings / Predictive Oncology Inc.

Predictive Oncology Inc.: Form D filings

Predictive Oncology Inc., a company in Pittsburgh, PA, filed 25 Form D notices with the SEC between 2009 and 2025. The latest, on October 22, 2025, reports $173.3 million sold of a $173.3 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
91 43RD STREET, SUITE 110, Pittsburgh, PA, 15201
Phone
(412) 432-1500
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1446159

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 22, 2025New notice$173,274,405$173,274,40520Oct 7, 2025sec.gov
Oct 22, 2025New notice$50,769,628$50,769,62829Oct 7, 2025sec.gov
Sep 8, 2025New notice$413,093$413,0931Aug 26, 2025sec.gov
Aug 2, 2024New notice$2,161,032$2,161,0328Jul 26, 2024sec.gov
Jun 2, 2022Amendment$2,302,368$2,302,3684May 18, 2022sec.gov
Jun 2, 2022New notice$2,302,368$2,302,3684May 18, 2022sec.gov
Mar 18, 2021New notice$17,635,343$17,635,34319Feb 23, 2021sec.gov
Mar 18, 2021Amendment$16,760,975$16,760,97510Jan 12, 2021sec.gov
Feb 2, 2021New notice$9,371,971$9,371,97110Jan 12, 2021sec.gov
Jul 10, 2020New notice$1,750,000$1,750,00018Jul 1, 2020sec.gov
Mar 30, 2020New notice$3,500,000$3,500,0002Mar 19, 2020sec.gov
Jul 29, 2019New notice$3,500,000$1,139,000$2,361,00011Jun 13, 2019sec.gov
Oct 11, 2018New notice$2,500,000$2,000,000$500,0002Sep 28, 2018sec.gov
Dec 12, 2017New notice$1,300,000$1,300,0001Nov 28, 2017sec.gov
Aug 6, 2014New notice$977,565$122,196$855,3691Jul 31, 2014sec.gov
Jul 24, 2014New notice$733,174$733,1742Jul 23, 2014sec.gov
Feb 5, 2014New notice$2,055,000$2,055,00016Jan 24, 2014sec.gov
Jun 20, 2013Amendment$1,000,000$1,000,00013May 17, 2013sec.gov
Jun 3, 2013New notice$1,000,000$550,000$450,0004May 17, 2013sec.gov
Mar 25, 2013New notice$500,000$500,0001Mar 14, 2013sec.gov
Feb 11, 2013New notice$500,000$154,000$346,0003Jan 28, 2013sec.gov
Jan 10, 2013New notice$300,000$275,000$25,0003Dec 26, 2012sec.gov
Dec 4, 2012Amendment$1,200,000$623,447$576,55325Jun 15, 2012sec.gov
Jun 29, 2012New notice$500,000$154,990$345,0107Jun 15, 2012sec.gov
Nov 4, 2009New notice$2,485,443$1,593,502$891,94132Jun 11, 2008sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Chuck S. NuzumDirector
Veena F. RaoDirector
Dan S. HadleyDirector
Gregory S. St. Clair, Sr.Director
Matthew S. HawrylukDirector
Raymond F. VennareExecutive Officer, Director
Josh S. BlacherExecutive Officer
Thomas L. McLaughlinExecutive Officer
Shawn S. MatthewsDirector

Other companies in Pennsylvania that filed recently

Every Form D from the week of Oct 20, 2025 · All recent filings in Pennsylvania · All recent Other filings

Read from SEC EDGAR. Amount sold is what Predictive Oncology Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.